Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation.
- Authors: Carlisi, D; D’Anneo, A; Angileri, L; Lauricella, M; Emanuele, S; Santulli, A; Vento, R; Tesoriere, G
- Publication year: 2011
- Type: Articolo in rivista (Articolo in rivista)
- Key words: Parthenolide; TRAIL; apoptosis; STAT3
- OA Link: http://hdl.handle.net/10447/54719